Last month, 17 top public health experts were abruptly removed from the U.S. Advisory Committee on Immunization Practices (ACIP), the group historically responsible for setting national vaccine guidelines. The move came directly from U.S. Health Secretary Robert F. Kennedy Jr., who dismissed the entire panel, accusing them of being too closely tied to vaccine manufacturers and too quick to approve vaccines without scrutiny.

In their place, Kennedy appointed several individuals known for their skepticism toward vaccines, a controversial decision that has sparked concern among the medical community.

READ MORE ON: RFK Jr. Removes Entire CDC Vaccine Advisory Committee

Kennedy Names New Vaccine Advisers Among Whom Are Anti-Vaxxers And Those Who Spread Misinformation

“A Travesty” of a First Meeting

In a strongly worded commentary published in the New England Journal of Medicine this week, the ousted experts criticized what they say is a dangerous shift in how vaccine policy is being handled. According to the former committee members, the new ACIP lacks rigorous scientific review and open discussion.

They pointed to the new committee’s first meeting in June as a troubling example.

The session included a presentation from a known anti-vaccine advocate warning against thimerosal, a preservative used in some flu vaccines, despite longstanding studies showing no link between thimerosal and neurodevelopmental disorders. Strikingly, the new panel did not hear from Centers for Disease Control and Prevention (CDC) scientists who could have presented data debunking the concerns.

Despite acknowledging the lack of evidence against thimerosal, the committee still voted to recommend removing it from vaccines.

ALSO READ: RFK Jr. Orders Thimerosal Removed From All US Flu Shots

“That meeting was a travesty, honestly,” said Dr. Yvonne Maldonado, a pediatric infectious disease expert from Stanford University and a former ACIP member, as reported by AP.

A Pattern of Destabilization

This isn’t the first time Kennedy’s decisions have raised eyebrows.

In May, he made headlines for halting the federal recommendation of COVID-19 vaccines for healthy children and pregnant women. The fired experts addressed this in an earlier essay published in the Journal of the American Medical Association, calling Kennedy’s choices “destabilizing.”

Now, their latest commentary goes further, warning that the current path could lead to long-term damage to public health. They argue that Kennedy and his newly selected panel are dismantling a once-trusted system that upheld science-based, unbiased vaccine guidance for decades.

Proposing a Way Forward

Recognizing the challenge of restoring the former ACIP structure, the ousted experts proposed new ideas for preserving trustworthy vaccine policy. They suggest forming an alternative committee, potentially independent from the federal government, to provide reliable recommendations.

“No viable pathway exists to fully replace the prior trusted and unbiased ACIP structure and process,” they wrote. “Instead, the alternatives must focus on limiting the damage to vaccination policy in the United States.”

Other suggestions included encouraging leading professional health organizations to collaborate on unified recommendations, or establishing an external group to audit ACIP’s guidance. However, the experts admitted that such efforts face major hurdles, especially regarding access to government-held data.

YOU MAY LIKE TO READ: RFK Hires Autism Skeptic To Look Into CDC Autism Data

Insurance Coverage and Access at Risk

Noel Brewer, a former committee member from the University of North Carolina, warned that insurers might selectively cover vaccines based on short-term cost savings. For example, the flu shot, which helps avoid immediate healthcare expenses, might be approved, while longer-term preventive vaccines, like the HPV shot, could be left out.

“That’s the danger,” Brewer said. “Vaccines that prevent future cancers might not make the cut.”

A Growing Controversy

Kennedy’s actions have not gone unnoticed in Congress. During a recent House hearing, Democratic lawmakers grilled him about his rapid and sweeping changes to national vaccine policy. So far, the U.S. Department of Health and Human Services has not responded to media inquiries regarding the criticism or the experts’ proposed solutions.

READ MORE: RFK Jr.’s Vaccine Panel Votes Against Flu Shot Preservative: All About The Controversial Thimerosal Ingredient

Breast cancer survivors have lived with a guarded sense of relief. Even after beating the disease, the possibility of recurrence remains a faint shadow but new research has raised an alarming possibility- respiratory viruses, including common ones like influenza and SARS-CoV-2, may act as a catalyst, reawakening dormant breast cancer cells that linger quietly in the lungs long after remission.

In a new study published in Nature, researchers from the University of Colorado and Utrecht University have found that viral infections can reignite cancer’s flame literally. Dormant cancer cells are like the embers left in an abandoned campfire, and respiratory viruses are like a strong wind that reignites the flames.

This study marks a crucial turning point in how we understand long-term remission and highlights the importance of continued vigilance among cancer survivors.

Also Read: Legionnaires Outbreak: All That You Need To Know About The Disease That Killed 1 And Left 22 Sick In New York

Why COVID-19 Infection Is First Red Flag?

The investigation kicked off in the aftermath of the COVID-19 pandemic. Clinicians and researchers began to notice an uptick in metastatic cancer cases, especially among individuals previously in remission. Something wasn’t adding up. Cancer recurrences were occurring at an unusual rate and too often to be dismissed as coincidence.

The researchers turned to two key data sources: the UK Biobank and a large U.S. breast cancer database with over 37,000 patient records. In the UK Biobank cohort, survivors who had contracted COVID-19 exhibited a twofold increase in cancer-related mortality. In the U.S. dataset, those with prior SARS-CoV-2 infection faced a more than 40% increase in metastatic breast cancer, particularly in the lungs.

The extent of this increased risk is almost unheard of in cancer epidemiology, it’s a significant effect.

What’s Happening in the Body?

To understand the mechanics, the researchers turned to mouse models—long used as reliable proxies for studying human disease behavior. When the mice with previously dormant breast cancer cells were infected with either SARS-CoV-2 or influenza A, it took only days for those latent cells to wake up. Within two weeks, there was a more than 100-fold increase in metastatic tumor burden in the lungs.

Here’s the crucial insight, the cancer cells didn’t reawaken because the virus directly interacted with them. Instead, the viruses triggered an inflammatory immune response, rich in signaling proteins called cytokines—especially interleukin-6 (IL-6). This cytokine storm appeared to create an environment ripe for dormant cancer cells to start proliferating again.

According to lead researcher Shi Chia from the University of Colorado, “Although species differences warrant caution in interpreting mouse data… collectively, these findings underscore the substantial metastatic risk COVID-19 posed to cancer survivors.”

Role of Viruses in Cancer Biology

The link between viruses and cancer isn’t new. Human papillomavirus (HPV) has long been known to cause cervical and other cancers. The Epstein-Barr virus (EBV) has been implicated in several types of lymphoma. In fact, EBV has been found in five times higher concentrations in breast cancer tissue compared to healthy tissue.

The idea that viruses could influence cancer development or recurrence has been around since the 1930s, particularly in mouse models. But this new research is among the first to show how non-oncogenic, respiratory viruses—those not traditionally associated with cancer—might still play a key role in its resurgence.

Role of Inflammation and the Immune System

One of the most compelling parts of the study is the insight into how the immune system's response, not the virus itself, may be the real driver of cancer recurrence.

After remission, it’s common for a few cancer cells known as dormant disseminated cancer cells (DCCs), to remain hidden in tissues like the lung, bone, or liver. These DCCs are typically inactive, posing no threat unless triggered.

Inflammatory responses to infections, especially those that involve cytokines like IL-6, appear to disturb this dormancy. In simple terms, inflammation acts like a wake-up call for these sleeping cells.

The researchers demonstrated that only when the viral infections resulted in elevated levels of inflammatory markers did the dormant cells awaken. This opens up new avenues for therapeutic research focused on blocking inflammation, rather than targeting cancer cells directly.

What This Means for Breast Cancer Survivors?

This is not a reason for panic but it is a call for caution. As DeGregori explains, “If you are a cancer patient who has these dormant cells, you may end up living a normal life and dying with these dormant cells, instead of dying because those dormant cells awakened. But if you get a respiratory virus like influenza or COVID, your chance of dying from those dormant cells awakening is much greater.”

Millions of breast cancer survivors around the world, many of whom are years or even decades into remission—could unknowingly carry dormant cells. For them, a common respiratory illness may no longer be just an inconvenience; it may be a risk factor for relapse.

Could Vaccination Be Protective?

Can we reduce this risk with vaccines? It’s too early to say definitively, but the idea is promising. If viral infections act as a trigger, then preventing infection might, in turn, prevent relapse.

DeGregori’s team is now exploring whether flu and COVID-19 vaccinations could lower the likelihood of dormant cell reactivation. This would have wide-ranging implications not just for cancer survivors, but for public health policy as a whole.

The idea that a respiratory virus could reignite cancer long after remission is unsettling but not entirely surprising. As science continues to unravel the complex relationship between our immune system, viruses, and cancer, this study offers one clear message:

Remission isn’t always the end and staying healthy may mean more than avoiding recurrence it could mean avoiding infection altogether.

With 6,000 cases of Legionnaires reported annually in the United States, scientists still think it is underdiagnosed as it could be hard to distinguish from other kinds of pneumonia or respiratory issues.

As of now, New York City has fallen prey to Legionnaires' disease outbreak. At least 22 people have fallen ill, and one person has been declared dead in Harlem, as per the New York City Health Department.

The Reason Of This Spread

As per the city health officials, people became ill after breathing in bacteria sprayed from cooling tower in central Harlem. Cooling towers help regulate building temperature. The city health department also said in a news release on Wednesday that it was testing cooling towers in the area and are continuously investigating the outbreak.

What Is The Legionnaire's Disease?

As per the Centers for Disease Control and Prevention (CDC), Legionnaire's disease is a serious type of pneumonia that is caused by Legionella bacteria. This bacteria is known for causing two types of diseases, one of them being Legionnaire's disease, a severe form of pneumonia; while the other one is Pontiac fever, which is a mild illness that can include fever, muscle aches and headaches.

It is very rare that this bacteria can cause infection outside of the lungs and affect heart or wound infections, notes CDC.

Common Symptoms

Legionnaires' disease symptoms usually develop 2 to 14 days after exposure to Legionella bacteria, but it can take longer.

The symptoms of Legionnaires' disease are similar to other types of pneumonia.

Symptoms include:

• Cough
• Fever
• Headaches
• Muscle aches
• Shortness of breath

Other symptoms, such as confusion, diarrhea, or nausea can also occur.

After this outbreak, which has been linked with a cluster, the deputy commissioner of division of infectious diseases at the New York City Department of Health and Mental Hygiene, Dr Celia Quinn, said that the risk is low for most people, however, there could be additional cases linked with this cluster.

Legionnaire's Disease in the US

Cases have been steadily rising over the past two decades. While there isn’t a single known cause for this increase, experts believe several factors may be contributing, including aging water infrastructure, poor system maintenance, rising water temperatures, and improved disease tracking and awareness.

Outbreaks are more common during the warmer months, particularly summer, when more buildings rely on cooling towers for air conditioning systems.

Health professionals note that while a similar report in winter might raise fewer concerns, the combination of summer heat and rising case numbers highlights the importance of staying vigilant during peak Legionella season.

Who Are At Risk?

While most healthy people exposed to the bacteria do not get sick, people who are 50 or older, or are current or former smokers, or people with a weakened immune system or chronic conditions, such as cancer, lung disease, diabetes or kidney and liver failure may be at a higher risk.

Legionnaires’ disease often becomes more severe within the first week of symptoms. In serious cases, patients may need hospitalization and oxygen support. If the illness progresses, it can lead to complications like lung failure or heart damage. According to the CDC, about 1 in 10 people who contract Legionnaires’ disease do not survive.

Is It Contagious?

Legionnaires’ disease doesn’t spread from person to person. It’s usually contracted by breathing in mist or vapor contaminated with the bacteria. Outbreaks are often linked to cooling towers in large cities. In rare instances, the illness can also be caused by inhaling contaminated soil.

After wrapping up a two-year long world tour, pop icon Justin Timberlake, 44, opened up about a private health battle that’s been affecting him behind the scenes. In a heartfelt Instagram post shared on Thursday, the singer revealed that he has been diagnosed with Lyme disease, a tick-borne illness that can cause lingering and unpredictable symptoms.

The announcement came just one day after the conclusion of his tour in Istanbul, marking the end of a musical chapter that spanned more than 70 performances across North America, Europe, and South America.

Diagnosis Behind the Scenes

Timberlake disclosed that during his Forget Tomorrow World Tour, which promoted his sixth solo album Everything I Thought It Was, he had been quietly “battling some health issues.”

“When I first got the diagnosis, I was shocked for sure,” Timberlake wrote. “But at least I could understand why I would be onstage and in a massive amount of nerve pain, or just feeling crazy fatigue or sickness.”

He admitted that the symptoms forced him to reconsider continuing the tour, saying, “I was faced with a personal decision. Stop touring? I decided the joy that performing brings me far outweighs the fleeting stress my body was feeling.”

Despite the physical toll, Timberlake pushed through his JT LIVE 25 tour leg, which included festival performances like Lollapalooza Brazil, before finally wrapping things up on July 31.

What Is Lyme Disease?

Lyme disease is caused by bacteria transmitted to humans through the bite of an infected black-legged tick. It's most common in certain parts of North America and Europe, especially during the warmer months.

The most common early sign of Lyme is a red rash that often resembles a bull’s-eye, typically appearing within 3 to 30 days after the bite.

The Center for Disease Control and Prevention (CDC), US, notes that the early symptoms can also mimic the flu, fever, chills, headache, fatigue, and muscle aches. If caught early and treated with antibiotics, most people recover completely within a few weeks.

However, for some, like Timberlake, symptoms can persist or worsen even after treatment. This condition, sometimes called Post-Treatment Lyme Disease Syndrome (PTLDS), includes ongoing fatigue, nerve pain, cognitive issues, and more.

“Lyme can be incredibly tricky because its symptoms overlap with many other conditions,” explained Dr. Christopher Bazzoli, an emergency medicine expert at the Cleveland Clinic, as reported by the New York Times. “When it’s not caught early, it can lead to a wide range of complications, from joint pain to neurological issues.”

In some untreated or severe cases, complications can include:

• Chronic fatigue
• Arthritis
• Heart palpitations
• Dizziness or shortness of breath
• Nerve pain
• Memory or concentration problems
• And in rare instances, meningitis

Doctors are still researching why some people recover quickly while others experience long-term effects. For now, treatment usually includes rest, medications for symptom relief, and in some cases, extended antibiotic therapy.

Timberlake has now joined a growing list of celebrities, including Avril Lavigne and Shania Twain, who’ve opened up about their experiences with Lyme disease in hopes of raising awareness.

Takeaway For You: If you’ve spent time in wooded or grassy areas and experience unusual fatigue, joint pain, or rashes, it’s worth getting checked for Lyme. Early diagnosis can make all the difference.